FIBROMYALGIA SYNDROME AND DISEASE BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS AT BACH MAI HOSPITAL
Main Article Content
Abstract
Objectives: 1. To evaluate the characteristics of fibromyalgia syndrome (FMS) in patients with rheumatoid arthritis (RA) treated at Bach Mai Hospital. 2. To assess the impact of fibromyalgia syndrome on the quality of life of the study group using the EQ-5D scale. Study Subjects: A total of 80 patients with rheumatoid arthritis, diagnosed according to the ACR 1987 and ACR/EULAR 2010 criteria, who were treated at Bach Mai Hospital from September 2024 to February 2025. Methods: A cross-sectional descriptive study was conducted. All participating patients were interviewed about their medical history and underwent clinical examinations to identify symptoms of FMS. Fibromyalgia syndrome was diagnosed based on the ACR 2016 criteria. Results and Conclusion: The prevalence of fibromyalgia syndrome in the study group was 37.5%. The characteristic symptoms of FMS observed in the patients included fatigue, sleep disorders, chronic headaches, and depression, leading to a significant reduction in quality of life. Patients with coexisting FMS had a significantly higher number of tender joints and greater joint pain severity, as assessed by the VAS scale, compared to those without FMS. Additionally, the proportion of patients with high disease activity was much higher in the FMS group than in the non-FMS group. These findings emphasize the importance of early detection of FMS in RA patients to prevent overestimation of disease activity, optimize treatment, and improve patients' quality of life.
Article Details
Keywords
Rheumatoid arthritis, fibromyalgia syndrome, EQ-5D questionnaire, quality of life
References
2. Ferreira LN, Ferreira PL, Baleiro RR. "Health-related quality of life in patients with rheumatoid arthritis". Acta Reumatol Port, 2008, 33(3), 42-331.
3. Fitzcharles MA, and et al. "Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines". Evid Based Complement Alternat Med, 2013, 528952.
4. Kim SC and et al. "Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia". Arthritis Res Ther, 2015, 17(1):18.
5. McInnes IB, Schett G. "The Pathogenesis of Rheumatoid Arthritis". New England Journal of Medicine, 2011, 365(23), 2205 – 2219.
6. Pouchot J, and et al. "Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis". J Clin Epidemiol, 2008, 61(7), 13 – 705.
7. Wolfe F, and et al. "2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria". Seminars in Arthritis and Rheumatism, 2016, 46(3): 319–329.
8. Yunus Durmaz, Ilker Ilhanli. "Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome". Ann Saudi Med, 2021, 41(4): 246-252.